.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Novartis
Farmers Insurance
UBS
Chubb
Mallinckrodt
Deloitte
Teva
Cipla
Julphar

Generated: July 26, 2017

DrugPatentWatch Database Preview

DEMADEX Drug Profile

« Back to Dashboard

What is the patent landscape for Demadex, and what generic Demadex alternatives are available?

Demadex is a drug marketed by Mylan Speciality Lp and Roche and is included in two NDAs.

The generic ingredient in DEMADEX is torsemide. There are sixteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the torsemide profile page.

Summary for Tradename: DEMADEX

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list2
Bulk Api Vendors: see list70
Clinical Trials: see list5
Patent Applications: see list3,051
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DEMADEX at DailyMed

Pharmacology for Tradename: DEMADEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Speciality Lp
DEMADEX
torsemide
TABLET;ORAL020136-001Aug 23, 1993ABRXYesNo► Subscribe► Subscribe► Subscribe
Mylan Speciality Lp
DEMADEX
torsemide
TABLET;ORAL020136-004Aug 23, 1993ABRXYesNo► Subscribe► Subscribe► Subscribe
Mylan Speciality Lp
DEMADEX
torsemide
TABLET;ORAL020136-002Aug 23, 1993ABRXYesNo► Subscribe► Subscribe► Subscribe
Mylan Speciality Lp
DEMADEX
torsemide
TABLET;ORAL020136-003Aug 23, 1993ABRXYesYes► Subscribe► Subscribe► Subscribe
Roche
DEMADEX
torsemide
INJECTABLE;INJECTION020137-001Aug 23, 1993DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: DEMADEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Speciality Lp
DEMADEX
torsemide
TABLET;ORAL020136-002Aug 23, 1993► Subscribe► Subscribe
Mylan Speciality Lp
DEMADEX
torsemide
TABLET;ORAL020136-004Aug 23, 1993► Subscribe► Subscribe
Roche
DEMADEX
torsemide
INJECTABLE;INJECTION020137-002Aug 23, 1993► Subscribe► Subscribe
Mylan Speciality Lp
DEMADEX
torsemide
TABLET;ORAL020136-003Aug 23, 1993► Subscribe► Subscribe
Roche
DEMADEX
torsemide
INJECTABLE;INJECTION020137-002Aug 23, 1993► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Julphar
Fish and Richardson
Citi
Dow
Deloitte
McKinsey
Boehringer Ingelheim
Queensland Health
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot